A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

Clinical trial NCT02972658 · TERMINATED

Trial details

NCT number: NCT02972658
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2017-03-15
Primary completion: 2018-10-02
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.